Haemonetics Corp (NYSE: HAE) is -11.57% lower on its value in year-to-date trading and has touched a low of $67.26 and a high of $97.97 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HAE stock was last observed hovering at around $69.47 in the last trading session, with the day’s loss setting it -0.42%.
Currently trading at $69.05, the stock is -7.34% and -12.92% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.13 million and changing -0.60% at the moment leaves the stock -15.82% off its SMA200. HAE registered -13.96% loss for a year compared to 6-month loss of -23.32%. The firm has a 50-day simple moving average (SMA 50) of $79.2916 and a 200-day simple moving average (SMA200) of $82.0301.
The stock witnessed a -9.86% gain in the last 1 month and extending the period to 3 months gives it a -5.54%, and is -2.50% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.67% over the week and 3.93% over the month.
Haemonetics Corp (HAE) has around 3657 employees, a market worth around $3.47B and $1.36B in sales. Current P/E ratio is 28.68 and Fwd P/E is 13.09. Profit margin for the company is 9.10%. Distance from 52-week low is 2.66% and -29.52% from its 52-week high. The company has generated returns on investments over the last 12 months (5.90%).
with sales reaching $352.88M over the same period.The EPS is expected to grow by 15.92% this year, but quarterly earnings will post 6.48% year-over-year. Quarterly sales are estimated to grow 4.95% in year-over-year returns.
Haemonetics Corp (HAE) Top Institutional Holders
428.0 institutions hold shares in Haemonetics Corp (HAE), with institutional investors hold 114.55% of the company’s shares. The shares outstanding are 50.38M, and float is at 49.67M with Short Float at 9.99%. Institutions hold 113.53% of the Float.
The top institutional shareholder in the company is CAPITAL RESEARCH GLOBAL INVESTORS with over 6.92 million shares valued at $572.1 million. The investor’s holdings represent 13.6161% of the HAE Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.96 million shares valued at $493.0 million to account for 11.7335 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 5.14 million shares representing 10.1221% and valued at over $425.29 million, while WELLINGTON MANAGEMENT GROUP LLP holds 7.5568 of the shares totaling 3.84 million with a market value of $317.51 million.
Haemonetics Corp (HAE) Insider Activity
#####
Haemonetics Corp disclosed in a document filed with the SEC on Jul 26 ’24 that Strong Stewart W (President, Global Hospital) sold a total of 4,312 shares of the company’s common stock. The trade occurred on Jul 26 ’24 and was made at $91.15 per share for $0.39 million. Following the transaction, the insider now directly holds 18196.0 shares of the HAE stock.
Still, SEC filings show that on Jul 26 ’24, Strong Stewart W (Officer) Proposed Sale 4,312 shares at an average price of $91.15 for $0.39 million. The insider now directly holds shares of Haemonetics Corp (HAE).
